EWJ vs XBI
iShares MSCI Japan ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for EWJ.
- • EWJ pays a higher dividend yield (3.81%).
Side-by-side metrics
| Metric | EWJ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 3.81% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $22.31B | $10.73B |
YTD return | 15.23% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.83 | 1.10 |
P/E ratio | 18.69 | — |
Last price | $93.67 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
EWJ top holdings
| 8035.T | Tokyo Electron Ltd | 4.17% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 4.14% |
| 285A.T | Kioxia Holdings Corp Ordinary Shares | 3.40% |
| 7203.T | Toyota Motor Corp | 3.12% |
| 6857.T | Advantest Corp | 2.86% |
| 8316.T | Sumitomo Mitsui Financial Group Inc | 2.79% |
| 9984.T | SoftBank Group Corp | 2.67% |
| 6501.T | Hitachi Ltd | 2.39% |
| 6758.T | Sony Group Corp | 2.31% |
| 6981.T | Murata Manufacturing Co Ltd | 2.23% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EWJ
EWJ (iShares MSCI Japan ETF) is Japanese large- and mid-cap equities. Managed by iShares, the fund carries $22.3B in assets under management, an expense ratio of 0.49%, a dividend yield of 3.81%. Its largest holding is Tokyo Electron Ltd (8035.T), which represents 4.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.